Aerie Pharmaceuticals (AERI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
Operating Expenses | 19,641 | 15,973 | 13,174 | 11,843 | 8,982 |
Operating Income | -19,641 | -15,973 | -13,174 | -11,843 | -8,982 |
Other Income | 2,402 | -528 | 27 | 29 | 2,311 |
Pre-tax Income | -17,239 | -16,501 | -13,147 | -11,814 | -6,671 |
Net Income Continuous | -17,239 | -16,501 | -13,147 | -11,814 | -6,671 |
Net Income | $-17,239 | $-16,501 | $-13,147 | $-11,814 | $-6,671 |
EPS Basic Total Ops | -0.70 | -0.69 | -0.54 | -0.49 | -0.28 |
EPS Basic Continuous Ops | -0.70 | -0.68 | -0.54 | -0.49 | -0.28 |
EPS Diluted Total Ops | -0.70 | -0.69 | -0.54 | -0.49 | -0.28 |
EPS Diluted Continuous Ops | -0.70 | -0.68 | -0.54 | -0.49 | -0.28 |
EBITDA(a) | $-19,377 | $-15,704 | $-13,065 | $-11,726 | $-8,911 |